Tibetan medicine salidroside improves host anti-mycobacterial response by boosting inflammatory cytokine production in zebrafish
The treatment for tuberculosis (TB), especially multidrug-resistant TB (MDR-TB), has a prolonged cycle which can last up to a year. This is partially due to the lack of effective therapies. The development of novel anti-TB drugs from the perspective of host immune regulation can provide an important...
Main Authors: | Shumei He, Hongyan Fan, Bin Sun, Meipan Yang, Hongxu Liu, Jianwei Yang, Jianxin Liu, Sizhu Luo, Zihan Chen, Jing Zhou, Lu Xia, Shulin Zhang, Bo Yan |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-08-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2022.936295/full |
Similar Items
-
An Approach to Characterizing the Complicated Sequential Metabolism of Salidroside in Rats
by: Zhiqiang Luo, et al.
Published: (2016-05-01) -
Study of Salidroside and Its Inflammation Targeting Emulsion Gel for Wound Repair
by: Xiaojie Wang, et al.
Published: (2023-06-01) -
Therapeutic potential and molecular mechanisms of salidroside in ischemic diseases
by: Jingxuan Han, et al.
Published: (2022-08-01) -
Salidroside provides neuroprotection by modulating microglial polarization after cerebral ischemia
by: Xiangrong Liu, et al.
Published: (2018-02-01) -
Protective effects of salidroside on chronic heart failure in rats and the underlying mechanisms
by: Chengxi Zhang, et al.